Skip to content

Asian Morbidity Survey (Vietnam)

Asian Morbidity Survey (Vietnam)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28179
Enrollment
1500
Registered
2018-09-25
Start date
2018-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional gastrointestinal disorders, functional abdominal pain, diarrhea, constipation, gastrointestinal disease

Interventions

this is an observational study

Sponsors

FrieslandCampina
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Infants and toddlers aged between 0 to 48 months old who are healthy children with normal physical development (according to growth chart) and physical examination (by pediatricians), will be eligible for enrolment 2. No organic gastrointestinal disorders

Exclusion criteria

Exclusion criteria: 1. Infants and toddlers who are identified as having organic gastrointestinal disorders (by pediatricians) 2. Infants and toddlers who have physical and/or mental retardation 3. Infants and toddlers who have had gastrointestinal surgeries 4. If, in the investigator's opinion, continuation in the survey would be detrimental to the subject’s well-being 5. Infants and toddlers who are lost to follow-up

Design outcomes

Primary

MeasureTime frame
Prevalence of infant colic Prevalence of infant regurgitation Prevalence of dyschezia Prevalence of functional diarrhea Prevalence of functional constipation

Secondary

MeasureTime frame
1. To identify risk factors associated with the development of FGD’s, such as demographic data, exposure to traumatic events, social and economic factors. The questionnaire will obtain family information (part 3 of the Questionnaire Assessment of functional gastrointestinal disorder) which could indicate the above risk factors. 2. To explore the relationship between various food groups and gastrointestinal symptoms in infants and toddlers between the age of 6.1 months – 48 months old. 3. To evaluate the accuracy of the criteria for diagnosis, using short-term clinical follow-up as the gold standard.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)